BioSig Technologies Inc reports results for the quarter ended September 30 - Earnings Summary

Streamex

15/11/2024 14:14

* BioSig Technologies Inc  BSGM.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -60 cents.  The lone analyst forecast for the
quarter was for a loss of 20 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * BioSig Technologies Inc's reported EPS for the quarter was
a
loss of 12 cents​.
    * The company reported a quarterly loss of $1.94 million.
    * BioSig Technologies Inc shares had risen by 364.7% this
quarter and lost 66.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 100%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for BioSig
Technologies Inc is 2.50 
This summary was machine generated from LSEG data November 15 at
02:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.20          -0.12          Beat
 Jun. 30 2024      -0.10          -0.30          Missed
 Mar. 31 2024      -0.29          -0.36          Missed
 Dec. 31 2023      -0.50          -0.82          Missed